A detailed history of Ascent Group, LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Ascent Group, LLC holds 6,690 shares of BSX stock, worth $509,175. This represents 0.04% of its overall portfolio holdings.

Number of Shares
6,690
Previous 6,762 1.06%
Holding current value
$509,175
Previous $390,000 17.44%
% of portfolio
0.04%
Previous 0.04%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$57.6 - $68.62 $4,147 - $4,940
-72 Reduced 1.06%
6,690 $458,000
Q4 2023

Feb 13, 2024

BUY
$48.64 - $57.81 $14,737 - $17,516
303 Added 4.69%
6,762 $390,000
Q3 2023

Nov 14, 2023

BUY
$50.19 - $54.68 $27,152 - $29,581
541 Added 9.14%
6,459 $341,000
Q2 2023

Aug 14, 2023

SELL
$49.72 - $54.64 $15,413 - $16,938
-310 Reduced 4.98%
5,918 $320,000
Q1 2023

May 10, 2023

BUY
$45.09 - $50.03 $280,820 - $311,586
6,228 New
6,228 $311,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $109B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Ascent Group, LLC Portfolio

Follow Ascent Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ascent Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ascent Group, LLC with notifications on news.